Anti-inflammatory potential of myricetin in leukemia cells: in silico and in vitro exploration

Nishad, Khushbu; Usha, Talambedu; Kumar, H. P. Prashanth; Ramesh, Nijalingappa; Middha, Sushil Kumar

doi:10.1007/s13596-023-00740-z

ADV TRADIT MED (ADTM)

2024

DOI: 10.1007/s13596-023-00740-z

|View full text |Cite

Anti-inflammatory potential of myricetin in leukemia cells: in silico and in vitro exploration

Khushbu Nishad,

Talambedu Usha,

H. P. Prashanth Kumar

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Preprint1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Exploring Mechanistic Insights and Apoptotic Gene Expression Induced by Myricetin Through In-Vitro and In-Silico Approaches

Nishad,

Usha,

Kumar

et al. 2024

Preprint

View full text Add to dashboard Cite

Myricetin demonstrates considerable potential in the area of anticancer research. It is known to be recognized as a rich natural polyphenolic flavonoid found abundantly in diverse dietary sources. This study investigates the impact of myricetin on cellular processes, including cell death, cell cycle regulation, and the expression of apoptotic genes in MCF-7 breast cancer cells. The cytotoxicity of myricetin was assessed using the MTT assay and cell cycle analysis on MCF-7 cells. Propidium iodide or Annexin V flow cytometric analysis was used to confirm apoptosis. Quantitative real-time PCR was used to measure the gene expression linked to apoptosis in MCF-7 cells following a 24-hour myricetin administration. Molecular docking was employed to probe the binding of myricetin to BCL-2. The cytotoxicity of myricetin revealed an IC50 of 5.06 µg/100 µl at 24 hours. Myricetin induced apoptosis in the Sub G0/G1 phase (10.38%). The findings showed up-regulation of the antiapoptotic gene BCL-2, along with elevated expression of caspase-9 and caspase-7, while the caspase-3 gene exhibited down-regulation. In silico analysis further confirmed the efficient binding of myricetin to BCL-2. The findings suggest that Myricetin exhibits a potent apoptotic effect by inhibiting cell cycle progression, however, further in-vivo investigations are necessary to understand the complexity of this molecule.

show abstract

Exploring Mechanistic Insights and Apoptotic Gene Expression Induced by Myricetin Through In-Vitro and In-Silico Approaches

Nishad,

Usha,

Kumar

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Anti-inflammatory potential of myricetin in leukemia cells: in silico and in vitro exploration

Cited by 1 publication

References 44 publications

Exploring Mechanistic Insights and Apoptotic Gene Expression Induced by Myricetin Through In-Vitro and In-Silico Approaches

Exploring Mechanistic Insights and Apoptotic Gene Expression Induced by Myricetin Through In-Vitro and In-Silico Approaches

Contact Info

Product

Resources

About